Literature DB >> 1710428

Heterogeneity of human mast cells and basophils in response to muscle relaxants.

C Stellato1, A de Paulis, R Cirillo, P Mastronardi, B Mazzarella, G Marone.   

Abstract

The authors studied the effects of increasing concentrations 10(-5)-10(-3) M) of four muscle relaxants (succinylcholine, d-tubocurarine, vecuronium, and atracurium) on histamine release from peripheral blood basophils and mast cells isolated from human lung parenchyma, skin tissues, and heart fragments. Basophil granulocytes released less than 5% of their histamine content when incubated with any one of the muscle relaxants tested. In contrast, mast cells showed a significant heterogeneity in response to different muscle relaxants. Succinylcholine did not induce histamine release from any type of mast cell, and only high concentrations of d-tubocurarine (10(-3) M) caused histamine release from skin and lung mast cells. Vecuronium concentration-dependently induced histamine release from skin and lung--but not from heart mast cells--to a maximum of 7.2 +/- 2.1% and 4.9 +/- 1.4%, respectively. Atracurium concentration-dependently caused significant histamine release from skin and lung mast cells to a maximum of 46.2 +/- 15.1% and 30.6 +/- 6.0%, respectively. Atracurium (5 x 10(-5) - 2 x 10(-4) M) also induced histamine release from heart mast cells. The histamine release process from both lung and skin mast cells caused by atracurium and vecuronium was extremely rapid (t1/2 = less than 1 min). The releasing activity of atracurium and vecuronium on lung and skin mast cells was not reduced, and not abolished, by lowering the temperature of the incubation buffer to 22 degrees C and 4 degrees C. Extracellular calcium did not affect the capacity of atracurium and vecuronium to induce histamine release from lung and skin mast cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710428     DOI: 10.1097/00000542-199106000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

Review 1.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 2.  Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

Authors:  Mariana Castells; Dean D Metcalfe; Luis Escribano
Journal:  Am J Clin Dermatol       Date:  2011-08-01       Impact factor: 7.403

Review 3.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 4.  Drugs and Vaccines Hypersensitivity in Children with Mastocytosis.

Authors:  Francesca Mori; Giuseppe Crisafulli; Annamaria Bianchi; Paolo Bottau; Silvia Caimmi; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Francesca Saretta; Carlo Caffarelli
Journal:  J Clin Med       Date:  2022-06-01       Impact factor: 4.964

Review 5.  Anesthetic considerations in pediatric mastocytosis: a review.

Authors:  Norma J Klein; Shad Misseldine
Journal:  J Anesth       Date:  2013-02-14       Impact factor: 2.078

Review 6.  Pediatric mastocytosis: routine anesthetic management for a complex disease.

Authors:  Melody C Carter; Ashraf Uzzaman; Linda M Scott; Dean D Metcalfe; Zenaide Quezado
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

Review 7.  Adverse reactions to neuromuscular blocking agents.

Authors:  Paul-Michel Mertes; Marie Claire Laxenaire
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.